Tim Shannon Joins Canaan Partners

Tim Shannon has joined Canaan Partners as a venture partner, with a focus on the healthcare sector. He previously was president and CEO of CuraGen Corp., a publicly-held oncology drug company acquired by Celldex Therapeutics in October.

1 December 2009•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail